QRG Capital Management Inc. Trims Holdings in Bath & Body Works, Inc. $BBWI

QRG Capital Management Inc. trimmed its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 81.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,244 shares of the company’s stock after selling 49,053 shares during the quarter. QRG Capital Management Inc.’s holdings in Bath & Body Works were worth $290,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in BBWI. Summit Investment Advisors Inc. purchased a new position in Bath & Body Works during the 1st quarter valued at about $1,292,000. Intech Investment Management LLC lifted its holdings in shares of Bath & Body Works by 53.5% in the second quarter. Intech Investment Management LLC now owns 58,460 shares of the company’s stock worth $1,751,000 after buying an additional 20,381 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Bath & Body Works by 11.5% in the second quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after acquiring an additional 733,000 shares during the period. GMT Capital Corp grew its stake in Bath & Body Works by 8.8% during the second quarter. GMT Capital Corp now owns 4,067,000 shares of the company’s stock valued at $121,847,000 after acquiring an additional 329,300 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp grew its stake in Bath & Body Works by 126.3% during the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 271,727 shares of the company’s stock valued at $8,141,000 after acquiring an additional 151,668 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, November 12th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday. Citigroup dropped their price objective on Bath & Body Works from $35.00 to $21.00 and set a “buy” rating for the company in a research note on Friday, November 21st. Guggenheim began coverage on Bath & Body Works in a research note on Tuesday, December 9th. They issued a “neutral” rating on the stock. Finally, Bank of America lowered their price target on Bath & Body Works from $40.00 to $32.00 and set a “buy” rating on the stock in a report on Thursday, November 20th. Five research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $23.53.

Bath & Body Works Trading Down 1.8%

BBWI opened at $22.17 on Friday. The stock has a market capitalization of $4.54 billion, a P/E ratio of 6.82, a PEG ratio of 0.81 and a beta of 1.51. The stock has a 50-day moving average price of $20.14 and a 200-day moving average price of $25.11. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $41.87.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.05). The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The firm’s quarterly revenue was down 1.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Friday, November 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.6%. The ex-dividend date was Friday, November 21st. Bath & Body Works’s dividend payout ratio is presently 24.62%.

More Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Zacks upgraded BBWI from “strong sell” to “hold,” which could temper selling pressure by some investors. Zacks Upgrade
• Neutral Sentiment: Brokerage consensus remains a “hold,” indicating analysts are not broadly bullish despite volatility. Consensus Hold
• Negative Sentiment: Multiple national law firms have filed or announced investigations and are soliciting lead plaintiffs in a securities‑class action alleging material misstatements/omissions covering June 4, 2024–Nov. 19, 2025 — raising the prospect of litigation costs, management distraction and reputational damage. Schall Law Firm Notice
• Negative Sentiment: Bleichmar Fonti & Auld and other firms cite a significant prior stock drop (reports reference a ~24% plunge) tied to the alleged disclosures, and are urging investors to contact counsel — this amplifies near‑term selling and uncertainty. BFA Fraud Alert
• Negative Sentiment: Additional plaintiff firms (Kessler Topaz, Rosen, Levi & Korsinsky, Bragar, Pomerantz, Faruqi, Kaplan Fox, and others) have issued alerts and deadline reminders for lead‑plaintiff motions (mid‑March deadlines), signaling broad, coordinated litigation activity. Kessler Topaz Alert

Insider Buying and Selling at Bath & Body Works

In related news, Director Stephen D. Steinour acquired 6,700 shares of the firm’s stock in a transaction dated Friday, November 21st. The shares were purchased at an average price of $14.86 per share, for a total transaction of $99,562.00. Following the completion of the acquisition, the director owned 48,175 shares in the company, valued at approximately $715,880.50. This represents a 16.15% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director Francis Hondal bought 3,343 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were bought at an average price of $14.99 per share, with a total value of $50,111.57. Following the completion of the acquisition, the director directly owned 21,554 shares in the company, valued at $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have acquired 33,513 shares of company stock valued at $500,442. Corporate insiders own 0.26% of the company’s stock.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.